Molecular methods to distinguish reactive and neoplastic lymphocyte expansions and their importance in transitional neoplastic states

Veterinary Clinical Pathology

Volumn 33, Issue 4, 2004, Pages 196-207

  Avery, Paul R ^a   Avery, Anne C ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Clonality assessment; Diagnosis; Gene expression profiling; Immunophenotyping; Lymphoma; Veterinary

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; IMMUNOGLOBULIN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ABDOMINAL PAIN; B CELL LYMPHOMA; BACTERIAL INFECTION; BODY WEIGHT DISORDER; CAT DISEASE; CELIAC DISEASE; CELL STIMULATION; CHROMOSOME ABERRATION; CYTOLOGY; DIARRHEA; DIGESTIVE SYSTEM CANCER; EHRLICHIA CANIS; EHRLICHIOSIS; ERADICATION THERAPY; GASTRITIS; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE REARRANGEMENT; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; INTESTINE LIPODYSTROPHY; INTESTINE LYMPHOMA; LEUKEMIA; LYME DISEASE; LYMPHADENOPATHY; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOSIS; LYMPHOID HYPERPLASIA; LYMPHOMA; MALIGNANT TRANSFORMATION; MANTLE CELL LYMPHOMA; MOLECULAR CLONING; MOLECULE; MONOCLONAL IMMUNOGLOBULINEMIA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; ONCOGENE; PATHOLOGIST; RELAPSE; REVIEW; SPLEEN CANCER; STOMACH LYMPHOMA; T CELL LEUKEMIA; T CELL LYMPHOMA; TROPHERYMA WHIPPELII; TUMOR CELL; WEIGHT REDUCTION;

ANIMALIA; HELICOBACTER; HELICOBACTER PYLORI;

EID: 12444310148     PISSN: 02756382     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2004.tb00374.x     Document Type: Review

References (83)

1. Walton RM, Hendrick MJ. Feline Hodgkin's-like lymphoma: 20 cases (1992-1999). Vet Pathol. 2001;38:504-511.
2. Heeb HL, Wilkerson MJ, Chun R, Ganta RR. Large granular lymphocytosis, lymphocyte subset inversion, thrombocytopenia, dysproteinemia, and positive Ehrlichia serology in a dog. J Am Anim Hosp Assoc. 2003;39:379-384.
3. Weiser MG, Thrall MA, Fulton R, et al. Granular lymphocytosis and hyperproteinemia in dogs with chronic ehrlichiosis. J Am Anim Hosp Assoc. 1991;27:84-88.
4. McDonough SP, Moore PF. Clinical, hematologic, and immunophenotypic characterization of canine large granular lymphocytosis. Vet Pathol. 2000;37:637-646.
5. Kirkness EF, Bafna V, Halpern AL, et al. The dog genome: survey sequencing and comparative analysis. Science. 2003;301:1898-4903.
6. Thomas R, Smith KC, Ostrander EA, Galibert F, Breen M. Chromosome aberrations in canine multicentric lymphomas detected with comparative genomic hybridisation and a panel of single locus probes. Br J Cancer. 2003;89:1530-1537.
7. Vernau W, Moore PF, An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction. Vet Immunol Immunopathol. 1999;69:145-164.
8. Workman HC, Vernau W. Chronic lymphocytic leukemia in dogs and cats: the veterinary perspective. Vet Clin North Am Small Anim Pract. 2003;33:1379-1399.
9. Leifer CE, Matus RE. Chronic lymphocytic leukemia in the dog: 22 cases (1974-1984). J Am Vet Med Assoc. 1986;189:214-217.
10. Byrne KM, Kim HW, Chew BP, Reinhart GA, Hayek MG. A standardized gating technique for the generation of flow cytometry data for normal canine and normal feline blood lymphocytes. Vet Immunol Immunopathol. 2000;73:167-182.
11. Greeley EH, Ballam JM, Harrison JM, Kealy RD, Lawler DF, Segre M. The influence of age and gender on the immune system: a longitudinal study in Labrador Retriever dogs. Vet Immunol Immunopathol. 2001;82:57-71.
12. Codner EC, Farris-Smith LL. Characterization of the subclinical phase of ehrlichiosis in dogs. J Am Vet Med Assoc. 1986;189:47-50.
13. Tizard IR. Veterinary Immunology: An Introduction. Houston, TX: WB Saunders; 2000:79.
14. Lemaire LC, van Deventer SJ, van Lanschot JJ, et al. Phenotypical characterization of cells in the thoracic duct of patients with and without systemic inflammatory response syndrome and multiple organ failure. Scand J Immunol. 1998;47:69-75.
15. Rezuke WN, Abernathy EC, Tsongalis GJ. Molecular diagnosis of B- and T-cell lymphomas: fundamental principles and clinical applications. Clin Chem. 1997;43:1814-1823.
16. Rieux-Laucat F, Fischer A, Deist FL. Cell-death signaling and human disease. Curr Opin Immunol. 2003;15:325-331.
17. Jennings CD, Foon KA. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood. 1997;90:2863-2892.
18. Gorczyca W, Weisberger J, Liu Z, et al. An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry. Cytometry. 2002;50:177-190.
19. Daum S, Hummel M, Weiss D, et al. Refractory sprue syndrome with clonal intraepithelial lymphocytes evolving into overt enteropathy-type intestinal T-cell lymphoma. Digestion. 2000;62:60-65.
20. Appelbaum FR, Sale GE, Storb R, et al. Phenotyping of canine lymphoma with monoclonal antibodies directed at cell surface antigens: classification, morphology, clinical presentation, and response to chemotherapy. Hematol Oncol. 1984;2:151-168.
21. Caniatti M, Roccabianca P, Scanziani E, Paltrinieri S, Moore PF. Canine lymphoma: immunocytochemical analysis of fine-needle aspiration biopsy. Vet Pathol. 1996;33:204-212.
22. Day MJ. Immunophenotypic characterization of cutaneous lymphoid neoplasia in the dog and cat. J Comp Pathol. 1995;112:79-96.
23. Modiano JF, Smith R, Wojcieszyn J, et al. The use of cytochemistry, immunophenotyping, flow cytometry, and in vitro differentiation to determine the ontogeny of a canine monoblastic leukemia. Vet Clin Pathol. 1998;27:40-49.
24. Ponce F, Magnol JP, Marchal T, et al. High-grade canine T cell lymphoma/leukemia with plasmacytoid morphology: a clinical pathological study of nine cases. J Vet Diagn Invest. 2003;15:330-337.
25. Ruslander DA, Gebhard DH, Tompkins MB, Grindem CB, Page RL. Immunophenotypic characterization of canine lymphoproliferative disorders. In Vivo. 1997;11:169-172.
26. Grindem CB, Page RL, Ammerman BE, Breitschwerdt EB. Immunophenotypic comparison of blood and lymph node from dogs with lymphoma. Vet Clin Pathol. 1998;27:16-20.
27. Swerdlow SH. Genetic and molecular genetic studies in the diagnosis of atypical lymphoid hyperplasias versus lymphoma. Hum Pathol. 2003;34:346-351.
28. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-2317.
29. Jung D, Alt FW. Unraveling V(D)J recombination; insights into gene regulation. Cell 2004;116:299-311.
30. Attygalle A, Al-Jehani R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood. 2002;99:627-633.
31. Xu D, Du J, Schultz C, Ali A, Ratech H. Rapid and accurate detection of monoclonal immunoglobulin heavy chain gene rearrangement by DNA melting curve analysis in the Light-Cycler System. J Mol Diagn. 2002;4:216-222.
32. Diss TC, Watts M, Pan LX, Burke M, Linch D, Isaacson PG. The polymerase chain reaction in the demonstration of monoclonality in T cell lymphomas. J Clin Pathol. 1995;48:1045-1050.
33. Arber DA. Molecular diagnostic approach to non-Hodgkin's lymphoma. J Mol Diagn. 2000;2:178-190.
34. Bagg A, Braziel RM, Arber DA, et al. Immunoglobulin heavy chain gene analysis in lymphomas: a multi-center study demonstrating the heterogeneity of performance of polymerase chain reaction assays. J Mol Diagn. 2002;4:81-89.
35. Arber DA, Braziel RM, Bagg A, Bijwaard KE. Evaluation of T cell receptor testing in lymphoid neoplasms: results of a multicenter study of 29 extracted DNA and paraffin-embedded samples. J Mol Diagn. 2001;3:133-140.
36. Sadek I, Greer W, Foyle A. Diagnosis of lymphoproliferative disorders: experience of a single institution in the long-term follow-up of discordant cases. Clin Invest Med. 2000;23:366-375.
37. Rockman SP. Determination of clonality in patients who present with diagnostic dilemmas: a laboratory experience and review of the literature. Leukemia. 1997;11:852-862.
38. Burnett RC, Vernau W, Modiano JE, Olver CS, Moore PF, Avery AC. Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen-receptor genes. Vet Pathol. 2003;40:32-41.
39. Dreitz MJ, Ogilvie G, Sim GK. Rearranged T lymphocyte antigen-receptor genes as markers of malignant T cells. Vet Immunol Immunopathol. 1999;69:113-119.
40. Fivenson DP, Saed GM, Beck ER, Dunstan RW, Moore PF. T-cell receptor gene rearrangement in canine mycosis fungoides: Further support for a canine model of cutaneous T cell lymphoma. J Invest Dermatol. 1994;102:227-230.
41. Burnett RC, Thompson LJ, Avery AC. PCR for antigen-receptor rearrangements (PARR): an objective and specific assay for the diagnosis of lymphoma [abstract]. Vet Pathol. 2002;39:617.
42. Kyoda K, Nakamura S, Matano S, Ohtake S, Matsud T. Prognostic significance of immunoglobulin heavy chain gene rearrangement in patients with acute myelogenous leukemia. Leukemia. 1997;11:803-806.
43. Elenitoba-Johnson KS, Bohling SD, Mitchell RS, Brown MS, Robetorye RS. PCR analysis of the immunoglobulin heavy chain gene in polyclonal processes can yield pseudoclonal bands as an artifact of low B cell number. J Mol Diagn. 2000;2:92-96.
44. Platz SJ, Breuer W, Pfleghaar S, Minkus G, Hermanns W. Prognostic value of histopathological grading in canine extramedullary plasmacytomas. Vet Pathol. 1999;36:23-27.
45. Cangul IT, Wijnen M, Van Garderen E, van den Ingh TS. Clinico-pathological aspects of canine cutaneous and mucocutaneous plasmacytomas. J Vet Med A Physiol Pathol Clin Med. 2002;49:307-312.
46. Arun SS, Breuer W, Hermanns W. Immunohistochemical examination of light-chain expression (lambda/kappa ratio) in canine, feline, equine, bovine and porcine plasma cells. Zentralbl Veterinarmed A. 1996;43:573-576.
47. Campo E. Genetic and molecular genetic studies in the diagnosis of B-cell lymphomas I: mantle cell lymphoma, follicular lymphoma, and Burkitt's lymphoma. Hum Pathol. 2003;34:330-335.
48. Falini B, Mason DY. Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry. Blood 2002;99:409-426.
49. van Krieken JH, Langerak AW, San Miguel JF, et al. Clonality analysis for antigen-receptor genes: preliminary results from the Biomed-2 concerted action PL 96-3936. Hum Pathol. 2003;34:359-361.
50. Hahn KA, Richardson RC, Hahn EA, Chrisman CL. Diagnostic and prognostic importance of chromosomal aberrations identified in 61 dogs with lymphosarcoma. Vet Pathol. 1994;31:528-540.
51. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848-1854.
52. Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194:1639-1647.
53. Wiestner A, Rosenwald A, Barry TS, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood. 2003;101:4944-4951.
54. Orchard JA, Ibbotson RE, Davis Z, et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet. 2004;363:105-111.
55. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet, 1991;338:1175-1176.
56. Lee SK, Lee YC, Chung JB, et al. Low grade gastric mucosa associated lymphoid tissue lymphoma: treatment strategies based on 10 year follow-up. World J Gastroenterol. 2004;10:223-226.
57. Neubauer A, Thiede C, Morgner A, et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. [see comment, Seymour JF. J Natl Cancer Inst. 1998;90:163-164]. J Natl Cancer Inst. 1997;89:1350-1355.
58. Liu H, Ye H, Ruskone-Fourmestraux A, et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H pylori eradication. Gastroenterology. 2002;122:1286-1294.
59. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet. 1993;342:571-574.
60. D'Elios MM, Amedei A, Manghetti M, et al. Impaired T-cell regulation of B-cell growth in Helicobacter pylori-related gastric low-grade MALT lymphoma. Gastroenterology. 1999;117:1105-1112.
61. Zucca E, Bertoni F, Roggero E, et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med. 1998;338:804-810.
62. Solnick JV, Schauer DB. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin Microbiol Rev. 2001;14:59-97.
63. Handt LK, Fox JG, Stalis IH, et al. Characterization of feline Helicobacter pylori strains and associated gastritis in a colony of domestic cats. J Clin Microbiol. 1995;33:2280-2289.
64. Simpson KW, Strauss-Ayali D, Scanziani E, et al. Helicobacter felis infection is associated with lymphoid follicular hyperplasia and mild gastritis but normal gastric secretory function in cats. Infect Immun. 2000;68:779-790.
65. Straubinger RK, Greiter A, McDonough SP, et al. Quantitative evaluation of inflammatory and immune responses in the early stages of chronic Helicobacter pylori infection. Infect Immun. 2003;71:2693-2703.
66. Enno A, O'Rourke JL, Hewlett CR, Dixon JA, Lee A. MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis: a mouse model of Helicobacter pylori-induced gastric lymphoma. Am J Pathol. 1995;147:217-222.
67. Greenberger NJ, Isselbacher KJ. Disorders of absorption. In: Fauci AS, Braun wald E, Isselbacher KJ, et al, eds. Harrison's Principles of Internal Medicine. 14th ed. New York, NY: McGraw-Hill; 1998:1616-1633.
68. Ryan BM, Kelleher D. Refractory celiac disease. Gastroenterology. 2000;119:243-251.
69. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology. 2000;119:234-242.
70. Bagdi E, Diss TC, Munson P, Isaacson PG. Mucosal intraepithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood. 1999;94:260-264.
71. Carbonell F, Grollet-Bioul L, Brouet JC, et al. Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood. 1998;92:3879-3886.
72. Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. Lancet. 2000;356:203-208.
73. Jergens AE, Moore FM, Haynes JS, Miles KG. Idiopathic inflammatory bowel disease in dogs and cats: 84 cases (1987-1990). J Am Vet Med Assoc. 1992;201:1603-1608.
74. Gabor LJ, Canfield PJ, Malik R. Immunophenotypic and histological characterisation of 109 cases of feline lymphosarcoma. Aust Vet J. 1999;77:436-441.
75. Gabor LJ, Malik R, Canfield PJ. Clinical and anatomical features of lymphosarcoma in 118 cats. Aust Vet J. 1998;76:725-732.
76. Zwahlen CH, Lucroy MD, Kraegel SA, Madewell BR. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997). J Am Vet Med Assoc. 1998;213:1144-1149.
77. Carreras JK, Goldschmidt M, Lamb M, McLear RC, Drobatz KJ. Feline epitheliotropic intestinal malignant lymphoma: 10 cases (1997-2000). J Vet Intern Med. 2003;17:326-331.
78. Pierce KR, Marrs GE, Hightower D. Acute canine ehrlichiosis: platelet survival and factor 3 assay. Am J Vet Res. 1977;38:1821-1825.
79. Harrus S, Waner T, Weiss DJ, Keysary A, Bark H. Kinetics of serum antiplatelet antibodies in experimental acute canine ehrlichiosis. Vet Immunol Immunopathol. 1996;51:13-20.
80. Breitschwerdt EB, Woody BJ, Zerbe CA, Buysscher EV, Barta O. Monoclonal gammopathy associated with naturally occurring canine ehrlichiosis. J Vet Intern Med. 1987;1:2-9.
81. Wang S, Ernst LM, Smith BR, et al. Systemic Tropheryma whippleii infection associated with monoclonal B-cell proliferation: a Helicobacter pylori-type pathogenesis? Arch Pathol Lab Med. 2003;127:1619-1622.
82. Galli-Stampino L, Pasqualini A, Pozzato G, et al. Molecular analysis of V(H)I+ B lymphocytes in HCV patients. Dig Liver Dis. 2003;35:788-794.
83. Hermine O, Lefrère F, Bronowicki J-P, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347:89-94.